期刊文献+

P53 codon 72 polymorphism and ovarian cancer risk:a meta-analysis 被引量:1

P53 codon 72 polymorphism and ovarian cancer risk:a meta-analysis
下载PDF
导出
摘要 Objective: p53 is a tumor suppressor gene and is involved in the etiology of ovarian cancer. Studies investigating the associations between the p53 codon 72 polymorphism and ovarian cancer risk showed conflicting results. We performed this meta-analysis from eligible studies to evaluate this purported relationship. Methods: This meta-analysis was performed from 9 case-control studies, including 825 ovarian cases and 1073 controls. The fixed and random effect models were used to estimate the odds ratios(ORs) for various contrasts of this polymorphism. Results: The combined results based on all studies showed that a significantly decreased risk was associated with the variant Pro/Pro genotype, compared with Arg/Pro+Arg/Arg genotypes(OR, 0.70; 95%CI, 0.51-0.95). When stratifying the studies by ethnicity, we found that individuals with the variant genotype Pro/pro had a significantly decreased risk of ovarian cancer compared with Arg/Arg genotype(OR, 0.43; 95%CI, 0.20-0.89) and Arg/Pro+Arg/Arg genotypes(OR, 0.61; 95%CI, 0.37-0.99) among Africans. Conclusion: This meta-analysis suggests that the p53 codon 72 polymorphism may contribute to genetic susceptibility to ovarian cancer. More studies based on larger sample size should be performed to confirm the findings. Objective: p53 is a tumor suppressor gene and is involved in the etiology of ovarian cancer. Studies investigating the associations between the p53 codon 72 polymorphism and ovarian cancer risk showed conflicting results. We performed this meta-analysis from eligible studies to evaluate this purported relationship. Methods: This meta-analysis was performed from 9 case-control studies, including 825 ovarian cases and 1073 controls. The fixed and random effect models were used to estimate the odds ratios(ORs) for various contrasts of this polymorphism. Results: The combined results based on all studies showed that a significantly decreased risk was associated with the variant Pro/Pro genotype, compared with Arg/Pro+Arg/Arg genotypes(OR, 0.70; 95%CI, 0.51-0.95). When stratifying the studies by ethnicity, we found that individuals with the variant genotype Pro/pro had a significantly decreased risk of ovarian cancer compared with Arg/Arg genotype(OR, 0.43; 95%CI, 0.20-0.89) and Arg/Pro+Arg/Arg genotypes(OR, 0.61; 95%CI, 0.37-0.99) among Africans. Conclusion: This meta-analysis suggests that the p53 codon 72 polymorphism may contribute to genetic susceptibility to ovarian cancer. More studies based on larger sample size should be performed to confirm the findings.
出处 《Journal of Nanjing Medical University》 2008年第5期279-285,共7页 南京医科大学学报(英文版)
基金 the National Natural Science Foun-dation of China(30571583 and 30271105) the Ph.D.Programs Foun-dation of Ministry of Education of China(20060312002) the NaturalScience Foundation of Jiangsu Province(BK2006231) the PostdoctoralScience Foundation of China(20060390293) the Postdoctoral ScienceFoundation of Jiangsu Province(0601049) "Qinglan Project"Fundation for the Young Academic Leader of Jiangsu Province(2006)
关键词 P53 ovarian cancer genetic susceptibility META-ANALYSIS P53 ovarian cancer genetic susceptibility meta-analysis
  • 相关文献

参考文献12

  • 1Elaine Cristina Morari,Andre Bacellar Costa Lima,Natassia Elena Bufalo,Janaina Luisa Leite,Fabiana Granja,Laura Sterian Ward.Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients[J].Journal of Cancer Research and Clinical Oncology.2006(8)
  • 2Radhakrishna M. Pillai,S. Sreevidya,Brad H. Pollock,P. Jayaprakash,Brian Herman.Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India[J].Journal of Cancer Research and Clinical Oncology.2002(11)
  • 3Scholz HS,,Tasdemir H,Hunlich T,Turnwald W,Both A,Egger H.Multivisceral cytoreductive surgery in FIGO stagesⅢC andⅣ epithelial ovarian cancer:results and 5-year follow-up[].Gynecologic Oncology.2007
  • 4Pillai MR,Sreevidya S,Pollock BH,Jayaprakash PG,Herman B.Polymorphism at codon 72 of p53,human papillomavirus,and cer- vical cancer in South India[].Journal of Cancer Research and Clinical Oncology.2002
  • 5Ganmaa D,Sato A.The possible role of female sex hormones in milk from pregnant cows in the development of breast,ovarian and corpus uteri cancers[].Medical Hypotheses.2005
  • 6Miller DP,Liu G,De Vivo I,Lynch TJ,Wain JC,Su L,et al.Com- binations of the variant genotypes of GSTP1,GSTM1,and p53 are associated with an increased lung cancer risk[].Cancer Research.2002
  • 7Lee JM,Lee YC,Yang SY,Shi WL,Lee CJ,Luh SP,et al.Geneticpolymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus[].International Journal of Cancer.2000
  • 8Zehbe I,Voglino G,Wilander E,Genta F,Tommasino M.Codon 72 polymorphism of p53 and its association with cervical cancer[].The Lancet.1999
  • 9Handoll HH.Systematic reviews on rehabilitation interventions[].Archives of Physical Medicine and Rehabilitation.2006
  • 10MidgetteAS,WongJB,BeshanskyJR,PorathA,FlemingC,Pauker SG.Cost-effectiveness of streptokinase for acute myocardial infarction:A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction[].Medical Decision Making.1994

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部